MT Group is a biotechnology services company specializing in the collection, processing, storage, and distribution of high-quality human biospecimens for pharmaceutical, biotechnology, and diagnostic research. Founded in 2003, the company supports drug development, biomarker discovery, and diagnostic testing by providing researchers with human tissue, blood, plasma, serum, and other biological samples. Through its global network of clinical collection sites, MT Group helps researchers study diseases, including cancer, autoimmune disorders, and cardiovascular conditions. The company focuses on delivering reliable biological samples accompanied by detailed clinical data to support the development of new treatments and diagnostic technologies.